Patrick Frost, PhD

Patrick Frost, PhD

Feb 10, 2016

Group 6 Copy 67
2
Please wait...

About This Project

BBRI and Los Angeles VA Medical Center

Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

Blast off!

Browse Other Projects on Experiment

Related Projects

Aptapaper: Detecting Pathogens on a Simple Piece of Paper

The Michigan Synthetic Biology Team is excited to be building Aptapaper, a device used to detect proteins...

Creating a neural network that classifies Dinoflagellate species

I think we have the technology to develop an artificial intelligence model that can differentiate between...

Squid in Space: Symbiosis and Innate Immunity

Astronauts experience dysregulated immune function in space that may be related to their microbial communities...

Backer Badge Funded